Showing results (131-140 of 301) with videos related to
Sort By:
Pageof 31
Annals of Hematology|July 10, 2023
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)Alexander Pohlmann, Eva Bentgens, Christoph Schülke, et al.Frontiers in Oncology|June 15, 2026
Health-related quality of life after autologous stem cell transplantation for multiple myeloma or lymphoma impacts professional activity- an analysis from two German tertiary care centersAnna Franziska Hamm, Ajelet Loesche, Christine Eisfeld, et al.European Journal of Haematology|July 12, 2018
90 Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experienceEva U Spukti, Lars Henning Schmidt, Arik Schulze, et al.Cancer Research|August 5, 2016
Splenic Marginal Zone Granulocytes Acquire an Accentuated Neutrophil B-Cell Helper Phenotype in Chronic Lymphocytic LeukemiaMarcel Gätjen, Franziska Brand, Michael Grau, et al.Cancer Research and Treatment|July 27, 2016
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic LeukemiaMathias Lutz, Arik B Schulze, Elisabeth Rebber, et al.Clinical Lymphoma, Myeloma & Leukemia|January 9, 2026
Survival Outcomes After Front-Line Consolidation With High-Dose Melphalan and Autologous Stem Cell Transplantation in Younger and Elderly Multiple Myeloma Patients: A Retrospective Bi-Centric AnalysisArne Strotmann, Theo Leitner, Paolo Mazzeo, et al.Molecular Imaging and Biology|September 5, 2019
Temporal Dynamics of Reactive Oxygen and Nitrogen Species and NF-κB Activation During Acute and Chronic T Cell-Driven InflammationJohannes Schwenck, Roman Mehling, Wolfgang M Thaiss, et al.Cancer Medicine|May 21, 2024
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in EuropeEnver Aydilek, Gerald Wulf, Friedrich Schwarz, et al.Bone Marrow Transplantation|May 3, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patientsPhilipp Berning, Lina Kolloch, Christian Reicherts, et al.Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma disseminationMélanie Juilland, Nagham Alouche, Ivana Ubezzi, et al.Pageof 31